Literature DB >> 15563438

The effects of a high calcium dairy food on bone health in pre-pubertal children in New Zealand.

Megan J Gibbons1, Nigel L Gilchrist, Christopher Frampton, Patricia Maguire, Penelope H Reilly, Rachel L March, Clare R Wall.   

Abstract

Childhood and adolescence is the period of most rapid skeletal growth in an individual's lifetime. A greater peak bone mass achieved in the first 2-3 decades of life, may protect against the risk of osteoporotic fracture in later life. The aim of this randomized, controlled study was to assess in pre-pubertal boys and girls (aged 8-10 years) the effect of 18 months of a calcium enriched, cocoa flavoured product on bone density, bone growth and bone size in New Zealand children. One hundred and fifty four pre-pubertal boys and girls (aged 8-10 years) were randomized to receive a high calcium dairy drink or a control drink reconstituted with water for 18 months. They were assessed at baseline and then every 6 months for the first 18 months, while they were having the supplement; they were then followed up 12 months after supplementation had finished. Bone mineral density and bone mineral content were assessed at the total body, hip and spine. Indicators of bone size (vertebral width and height) were also measured at the spine. Anthropometric data was collected, medical history questionnaires were administered (including the Tanner or pubertal stage questionnaire), dietary calcium intake was assessed with a calcium food frequency questionnaire and calcium supplement compliance was determined. There was no significant difference between the 2 groups for bone mineral density or bone mineral content at any time point. There was no difference in vertebral height or width at any stage of the study, indicating no additional influence on bone size at the lumbar vertebrae. There were no significant differences between height, weight, lean mass or fat mass at any time point. Both groups had higher habitual calcium intakes than recommended for this age group going into the study and throughout the study. In this 2(1/2) year study (18 months supplementation, 1 year follow-up) we did not observe a difference in bone mineral density in pre-pubertal children. This was probably due to their high habitual dietary calcium intake whereby minimal addition of calcium to the diet reached the threshold level where no further benefit was seen. There were no significant differences between the two groups in body composition. Growth and the mean height and weight remained between the 50th and 75th percentile for their age. We have shown calcium supplementation in children with high habitual dietary calcium intake appears not to have additional effects on bone mass. Calcium supplementation needs to be targeted in those children with low habitual dietary calcium intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563438

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  14 in total

1.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

2.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

3.  Effects of Milk and Milk-Product Consumption on Growth among Children and Adolescents Aged 6-18 Years: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Kai Kang; Olusola F Sotunde; Hope A Weiler
Journal:  Adv Nutr       Date:  2019-03-01       Impact factor: 8.701

Review 4.  The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.

Authors:  C M Weaver; C M Gordon; K F Janz; H J Kalkwarf; J M Lappe; R Lewis; M O'Karma; T C Wallace; B S Zemel
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

Review 5.  Physical activity, calcium intake and bone health in children and adolescents.

Authors:  Kristin S Ondrak; Don W Morgan
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

6.  Dairy product intake decreases bone resorption following a 12-week diet and exercise intervention in overweight and obese adolescent girls.

Authors:  Andrea R Josse; Izabella A Ludwa; Rozalia Kouvelioti; Melissa Calleja; Bareket Falk; Wendy E Ward; Panagiota Klentrou
Journal:  Pediatr Res       Date:  2020-03-16       Impact factor: 3.756

Review 7.  Calcium supplementation for improving bone mineral density in children.

Authors:  T M Winzenberg; K Shaw; J Fryer; G Jones
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 8.  Effects of Dairy Consumption on Body Composition and Bone Properties in Youth: A Systematic Review.

Authors:  Rozalia Kouvelioti; Andrea R Josse; Panagiota Klentrou
Journal:  Curr Dev Nutr       Date:  2017-07-07

9.  Dairy foods and bone health throughout the lifespan: a critical appraisal of the evidence.

Authors:  Sandra Iuliano; Tom R Hill
Journal:  Br J Nutr       Date:  2019-01-14       Impact factor: 3.718

10.  Maternal Dietary Supplementation with Oligofructose-Enriched Inulin in Gestating/Lactating Rats Preserves Maternal Bone and Improves Bone Microarchitecture in Their Offspring.

Authors:  Pilar Bueno-Vargas; Manuel Manzano; Javier Diaz-Castro; Inmaculada López-Aliaga; Ricardo Rueda; Jose María López-Pedrosa
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.